Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 127

Results For "EU"

6763 News Found

Teva study shows Huntington’s disease treatment improves life for patients & caregivers
Clinical Trials | June 24, 2026

Teva study shows Huntington’s disease treatment improves life for patients & caregivers

The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life


Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices
Medical Device | June 24, 2026

Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices

Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry


Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Biopharma | June 24, 2026

Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore

Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia


Shilpa Biologicals commissions rare integrated ADC manufacturing facility in India
News | June 24, 2026

Shilpa Biologicals commissions rare integrated ADC manufacturing facility in India

With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing


Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Drug Approval | June 23, 2026

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

The filing is backed by positive Phase 3 results recently published in JAMA Neurology


WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
News | June 23, 2026

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center

Clearing 19 biologics for Europe market


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego
Biotech | June 23, 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players


Teva closes $700M Emalex acquisition
News | June 23, 2026

Teva closes $700M Emalex acquisition

Bolstering neuroscience push with late-stage Tourette therapy


Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Biopharma | June 23, 2026

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making